Dendritic cell-mediated vaccination relies on interleukin-4 receptor signaling to avoid tissue damage after Leishmania major infection of BALB/c mice.

• Hauptverfasser: Anita Masic (VerfasserIn), Ramona Hurdayal (VerfasserIn), Natalie E Nieuwenhuizen (VerfasserIn), Frank Brombacher (VerfasserIn), Heidrun Moll (VerfasserIn)
• Format: Buch
• Veröffentlicht: Public Library of Science (PLoS), 2012-01-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Prevention of tissue damages at the site of Leishmania major inoculation can be achieved if the BALB/c mice are systemically given L. major antigen (LmAg)-loaded bone marrow-derived dendritic cells (DC) that had been exposed to CpG-containing oligodeoxynucleotides (CpG ODN). As previous studies allo...